Your browser doesn't support javascript.
loading
Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer.
Brock, Kristian; Homer, Victoria; Soul, Gurjinder; Potter, Claire; Chiuzan, Cody; Lee, Shing.
Afiliação
  • Brock K; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK. k.brock@bham.ac.uk.
  • Homer V; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Soul G; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Potter C; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Chiuzan C; Mailman School of Public Health, Columbia University, New York, NY, USA.
  • Lee S; Mailman School of Public Health, Columbia University, New York, NY, USA.
BMC Cancer ; 21(1): 777, 2021 Jul 05.
Article em En | MEDLINE | ID: mdl-34225682
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dose Máxima Tolerável / Relação Dose-Resposta a Droga / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dose Máxima Tolerável / Relação Dose-Resposta a Droga / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article